Tekmira Pharmaceuticals Corp (TKMR.OQ)

TKMR.OQ on NASDAQ Stock Exchange Capital Market

14.29USD
26 Dec 2014
Price Change (% chg)

$0.32 (+2.29%)
Prev Close
$13.97
Open
$14.03
Day's High
$14.32
Day's Low
$13.93
Volume
69,895
Avg. Vol
444,120
52-wk High
$31.37
52-wk Low
$7.47

TKMR.OQ

Chart for TKMR.OQ

About

Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing ribonucleic acid (RNA) interference (RNAi) therapeutics and providing its lipid nanoparticle (LNP) delivery technology to pharmaceutical and biotechnology partners. Its product candidates include TKM-HBV, TKM-PLK1, TKM-Ebola and TKM-Marburg.... (more)

Overall

No Ratios Available.

Financials

  TKMR.OQ Industry Sector
P/E (TTM): -- 159.35 38.84
EPS (TTM): -- -- --
ROI: -- -0.82 18.26
ROE: -- -1.98 19.12
Search Stocks

Tekmira to supply Ebola treatment for studies in West Africa

TORONTO - Tekmira Pharmaceuticals Corp will supply one of its experimental Ebola treatments for clinical studies to be conducted in West Africa by a consortium that includes England's Oxford university, the Canadian company said on Monday.

22 Dec 2014

Tekmira to supply Ebola treatment for studies in West Africa

TORONTO, Dec 22 - Tekmira Pharmaceuticals Corp will supply one of its experimental Ebola treatments for clinical studies to be conducted in West Africa by a consortium that includes England's Oxford university, the Canadian company said on Monday.

22 Dec 2014

Tekmira to produce Ebola treatment for U.S. Dept of Defense

- The U.S. Department of Defense has exercised an option with Canada's Tekmira Pharmaceuticals Corp for the company to make 500 courses of its experimental treatment for Ebola, Tekmira said on Thursday.

06 Nov 2014

UPDATE 1-Tekmira to produce Ebola treatment for U.S. Dept of Defense

Nov 6 - The U.S. Department of Defense has exercised an option with Canada's Tekmira Pharmaceuticals Corp for the company to make 500 courses of its experimental treatment for Ebola, Tekmira said on Thursday.

06 Nov 2014

Tekmira to produce Ebola treatment for U.S. Defense

Nov 6 - Canada's Tekmira Pharmaceuticals Corp has agreed to make 500 courses of its experimental treatment for Ebola for the U.S. Department of Defense, the company said on Thursday.

06 Nov 2014

Tekmira starts limited manufacturing of therapeutic for Ebola

- Canadian drugmaker Tekmira Pharmaceuticals Corp has begun limited manufacturing of a therapeutic targeting the Ebola-Guinea virus.

21 Oct 2014

UPDATE 1-Tekmira starts limited manufacturing of therapeutic for Ebola

(Adds background on other companies developing Ebola treatments)

21 Oct 2014

Tekmira begins limited manufacturing of drug targeting Ebola

Oct 21 - Canadian drugmaker Tekmira Pharmaceuticals Corp has begun limited manufacturing of a drug targeting the Ebola-Guinea virus that has killed more than 4,500 people, mostly in West Africa.

21 Oct 2014

Stock option volumes soar for biotechs with Ebola drugs

NEW YORK - The newest twist in the business of trying to capitalize on the outbreak of the Ebola virus is playing out in the U.S. equity options market.

09 Oct 2014

US STOCKS-RadioShack, Tekmira among biggest premarket movers

NEW YORK, Oct 3 - RadioShack Corp was one of the biggest movers in premarket trading Friday, jumping after Bloomberg reported that the troubled electronics retailer had reached a refinancing deal with Standard General.

03 Oct 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: GlobalData
$125.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks